Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin, and Amoxicillin

Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin, and Amoxicillin

<b>Background:</b> Prior research has raised concerns regarding the use of macrolides and their association with an increased risk of cardiovascular events. <b>Methods:</b> We conducted a cohort study, where we explored the cardiovascular risks associated with the treatment o...

Full description

Bibliographic Details
Main Authors: Imane Achir Alispahic, Josefin Eklöf, Pradeesh Sivapalan, Alexander Ryder Jordan, Zitta Barrella Harboe, Tor Biering-Sørensen, Jens-Ulrik Stæhr Jensen
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Journal of Clinical Medicine
Subjects:
COPD
major adverse cardiovascular event
stroke
AMI
cardiovascular death
clarithromycin
Online Access:https://www.mdpi.com/2077-0383/13/7/1987

Similar Items

Similar Items